
Sign up to save your podcasts
Or


The funding will deepen research into advanced biomarker modeling. Doctors say the company’s tools could streamline patient evaluations. The valuation reflects confidence in long-term impact.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
By Rich On Tech AIThe funding will deepen research into advanced biomarker modeling. Doctors say the company’s tools could streamline patient evaluations. The valuation reflects confidence in long-term impact.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.